PAUL A FRIEDMAN Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL A FRIEDMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL A FRIEDMAN. PAUL A FRIEDMAN is Chief Executive Officer in INCYTE CORP ($INCY) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Executive Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Cerulean Pharma Inc. ($CERU) and Director in Verastem, Inc. ($VSTM) and Director in Prelude Therapeutics Inc ($PRLD).

PAUL A FRIEDMAN in ALEXION PHARMACEUTICALS, INC.

Trading Symbol: ALXN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL A FRIEDMAN: Director
Holdings: 10,345 shares
Current Value: $1,321,263
Latest Transaction: May 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PAUL A FRIEDMAN in ALEXION PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALXN, DARE, INCY, SNTA, PRLD, VSTM

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 18 2020ALXNALEXION PHARMACEUT ...FRIEDMAN PAUL ADirectorGrantA0.003,468010,3456.9 K to 10.3 K (+50.43 %)
May 11 2018ALXNALEXION PHARMACEUT ...FRIEDMAN PAUL ADirectorGrantA0.002,17404,1512 K to 4.2 K (+109.96 %)
Nov 30 2017ALXNALEXION PHARMACEUT ...FRIEDMAN PAUL ADirectorGrantA0.001,97701,9770 to 2 K

Page:   1